Stemming the Rising Tide of New Viral Hepatitis Infections Globally

Nov 16 2024
Convention Center: Room 29
11:00 AM - 12:30 PM
Captured

World Class Speakers

Jason Grebely, PhD
Presenter

Jason Grebely, PhD

The Kirby Institute, UNSW Sydney
Jordan J. Feld, MD, MPH, FAASLD
Presenter

Jordan J. Feld, MD, MPH, FAASLD

Toronto General Hospital
Rania Tohme, MD, MPH
Presenter

Rania Tohme, MD, MPH

Centers for Disease Control and Prevention
JW
Moderator

John Ward, MD

Viral Hepatitis Action Coalition

Description

Prevention of new infections is key to achieving the goal of global HBV and HCV elimination. Experts in this session discuss HBV and HCV epidemiology; challenges and potential solutions to reducing infections globally; and the respective roles of policy, harm reduction, improved diagnostics, and innovation in treatment/vaccination to address the key pillar of infection prevention in the overall approach to achieve HBV and HCV elimination. 

Journey Maps

Objectives

  • Summarize the unique challenges in the prevention of new HBV and HCV infections.
  • Identify successful strategies to reduce new HBV and HCV infections using antiviral therapy combined with harm reduction.
  • Review remaining gaps in HBV vaccination.
  • Discuss progress regarding HCV vaccine development.
Chair

Norah Terrault, MD, MPH, FAASLD

University of Southern California